ASSET BASED LENDINGMorgan Credit Agreement • August 4th, 2016 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
CREDIT AGREEMENT dated as of June 1, 2016 (as it may be amended or modified from time to time, this "Agreement") among ACORDA THERAPEUTICS, INC., a Delaware corporation (the "Company"), CIVITAS THERAPEUTICS, INC., a Delaware corporation ("Civitas"), and NEURONEX, INC., a Delaware corporation ("Neuronex", and together with the Company, Civitas, and Neuronex, each, individually, a "Borrower" and collectively, the "Borrowers"), the other Loan Parties party hereto, the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent.
EFFECTIVE DATE – June 6, 2016 BIOGEN INTERNATIONAL GMBH (FORMERLY KNOWN AS "BIOGEN IDEC INTERNATIONAL GMBH") AND ACORDA THERAPEUTICS, INC. AMENDED AND RESTATED ADDENDUM #2 TO THE SUPPLY AGREEMENT BETWEEN ACORDA THERAPEUTICS, INC AND BIOGEN IDEC...Supply Agreement • August 4th, 2016 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances)
CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST. SUCH OMITTED PORTIONS, WHICH ARE MARKED WITH BRACKETS [ ] AND AN ASTERISK*, HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.
